Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Hemispherx Biopharma Inc (NYSE MKT LLC:HEB)

0.1865
Delayed Data
As of 9:43am ET
 +0.0005 / +0.27%
Today’s Change
0.17
Today|||52-Week Range
0.40
-25.40%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues161.0K213.0K150.0K197.0K
 
 
 
 
 
Cost of Goods Sold413.0K1.3M543.0K555.0K
 
 
 
 
 
Depreciation And Amortization630.0K683.0K691.0K696.0K
 
 
 
 
 
 
Operating ExpensesGross Income-882.0K-1.8M-1.1M-1.1M
 
 
 
 
 
General Expenses13.4M18.6M15.9M17.6M
 
 
 
 
 
Research And Development6.7M9.5M8.2M8.5M
 
 
 
 
 
Total Operating Expenses14.5M20.6M17.1M18.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-14.3M-20.3M-17.0M-18.7M
 
 
 
 
 
Extraordinary Credit2.5M94.0K281.0K14.0K
 
 
 
 
 
Extraordinary Charge0.000.00-976.0K-145.0K
 
 
 
Interest Expense On Debt41.0K24.0K159.0K11.0K
 
 
 
 
 
Other Expenses2.3M1.3M686.0K680.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.0M-17.4M-16.2M-17.5M
 
 
 
 
 
Net Income-9.0M-17.4M-16.2M-17.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS135.4M141.0M167.3M188.3M
 
 
 
 
 
Shares To Calculate EPS Diluted135.4M141.0M167.3M188.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.07-$0.12-$0.10-$0.09
 
 
 
 
 
EPS Diluted-$0.07-$0.12-$0.10-$0.09